SOME ACTUAL PROBLEMSIN DIAGNOSTIC, CLASSIFICATION AND PSYCHOPATHOLOGY OF SCHIZOPHRENIA
Keywords:
schizophrenia, analysis of the literature.Abstract
Thiswork, based on the analysis of world literature, provides data about the most important issues of classification, etiology and pathogenesis, diagnostic and clinical manifestations of schizophrenia. Shown that none of these issues has unambiguous interpretation today.
References
1. Психиатрия: справочник практического врача / Под ред. Гофмана А.Г. – М.: Медпрессинформ, 2006. – 591 с.
2. Джонс П. Шизофрени / П. Джонс, П. Бакли. – М.: Медпрессинформ, 2008. – 192 с.
3. Руководство по психиатрии. Т.1 / Под ред. Снежневского А.В. – М.: Медицина, 1983. – С. 299.
4. Руководство по психиатрии.Т.1 / Под ред. Тиганова А.С. – М.: Медицина, 1989.
5. Уотсон Д. ДНК и мозг (впоисках генов психических заболеваний) / Д. Уотсон // Лекция 3 июля 2008 г. в Москве, http://elementy.ru/lib/430639.
6. The spectrum of psychoyic disorders: neurobiology, etiology, and psthogenesis / Ahmed, Iqbal, Fujii, Daryl. – Cambridge, UK: Cambridge University Press, 2007.
7. Andreasen N.C. Negative symptoms in schizophrenia / N.C. Andreasen // Arch. Gen. Psychiatry. – 1982. – Vol.39. – P. 784-788.
8. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives / B. Arts, N. Jabben, L. Krabbendam et al. // Psychol. Med. – 2008. – Vol.38. – P. 771-785.
9. Awad A.G. The burden of schizophrenia on caregivers: a review / A.G. Awad, Voruganti L.N. // Pharmacoeconomics. – 2008. – Vol.26(2). – P. 149-162.
10. Benes F.M. Quantiativecytoarchitectural studies of the cerebral cortex of schizophrenics / F.M. Benes, J. Davidson, E.D. Bird // Arch. Gen. Psychiatry. – 1986. – Vol.43(1). – P. 31-35.
11. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond / Bora et al. // Schizophren. Bull. – 2010. – Vol.36. – P. 36-42.
12. Buchanan R.W. Schizophrenia. Introduction and overview / R.W. Buchanan, W.T. Carpenter, In: Kaplan B., Sadock V. // Comprehensive textbook of psychiatry. 7th edition, vol.I. – Philadelphia, Lippincotte, Williams and Wilkins. 2000. – P. 1096-1110.
13. genetic variation in MAOA modulates ventromedial prefrontal circuity mediating individual differences in human personality / J.W. Buckholtz, J.H. Callicott, B. Kolachana et al.// Mol. Psychiatry. – 2008. – Vol.13(3). – P. 313-324.
14. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia / J.H. Callicott, R.E. Straub, L. Pezawas et al. // Proc. Natl. Acad. Sci USA. – 2005. – Vol.102(24). – P. 8627-8632.
15. Campaign for The Abolition of The Schizophrenia Label (http://www/caslcampaign.com/).
16. Association of DISC1/TRAX halotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory / T.D. Cannon, W. Hennah, T.G. van Erp et al. // Arch. Gen. Psychiatry. – 2005. – Vol.62(11). – P. 1205-1213.
17. Collier D.A. Schizophrenia: the polygene princess and the pea / D.A. Colli¬er // Psychol. Med. – 2008. – P. 1-5.
18. Crespi Psychosis and autism as diametrical disorders of the social brain (http://www.bbsonline.org/Preprints/Crespi-02162007).
19. Crow T.J. The two syndrome concept, origins and current status / T.J. Crow // Schiz. Bull. – 1985. – Vol.11. – P. 471-477.
20. Crow T.J. How and why genetic linkage has not solved the problem of psychosis: rewiew and hypothesis / T.J. Crow // Am J. Psychiatry. – 2007. – V.164. – P. 13-21.
21. Crow T.J. The emperors of the schizophrenia polygene have no clothes / T.J. Crow // Psychol. Med. – 2008. – P. 1-5.
22. Cuesta M.J. Empirical validation of competing definitions of schi¬zophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis / M.J. Cuesta, V. Peralta, A. Zarzuela // Schizophr. Res. – 2007. – Vol.95. – P. 39-47.
23. Dysfunctional Perception Syndrome (http://astridvanwoerkom.wordpress.com/2009/10/09/schizophrenia-now¬called-dysfunctional-perception-syndrom/)
24. Neuropsychologic functioning among the nonspecific relatives of schi¬zophrenic patients: a four-year follow up study / S.V. Faraone, I.J. Seidman, W.S. Kremen et al. // J. Abnorm. Psychol. – 1999. – Vol.108. – P. 176-181.
25. Jackson J.H. Selected writings / J.H. Jackson. – Holder and Stoughton, London, 1931. – Vol.1. – 411 p.
26. The G72/G30 gene complex and cognitive abnormalities in schizophrenia / T.E. Goldberg, R.E. Straub, J.H. Callicott et al. // Neuropsychopharmacol¬ogy. – 2006. – Vol.31(9). – P. 2022-2032.
27. Green M.F. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS / M.F. Green, R.S. Kern, R.K. Heaton // Schizophr. Res. – 2004. – Vol.72(1). – P. 41-51.
28. Griesinger W. Die Pathologic und Therapie der psychischen Krankheiten / W. Griesinger. – Braunsduweig: Verlag von Friedrich Wreden, 1871. – Р. 53-85.
29. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms / J. Hall, H.C. Whalley, E. d. Job et al. // Nat. Neurosci. – 2006. – Vol.9(12). – P. 1477-1478.
30. Heinrichs R.W. The primacy of cognition in schizophrenia / R.W. Heinrichs // Am. Psychol. – 2005. – Vol.60(3). – P. 229-242.
31. Neuropsychological dysfunction in antipsychotic-naХve first-episode uni¬polar psychotic depression / S.K. Hill, M.S. Keshavan, M.E. Thase et al. // Am. J. Psychiatry. – 2004. – Vol.161(6). – P. 996-1003.
32. Hoche A. Die Medizin der Gegenwart in Sellbstdarstellungen, 1925.
33. Kay S.R. Cognitive abnormality in schizophrenia: A dual process model / S.R. Kay, M.M. Singh // Biol. Psychiat. – 1979. – Vol.14. – P. 155-176.
34. Keefe R.S. Defining a cognitive function decrement in schizophrenia / R.S. Keefe, C.E. Eesley, M.P. Poe // Biol. Psychiatry. – 2005. – Vol.57, №6. – P. 688-692.
35. A Separate Disease within the Syndrome of Schizophrenia / B. Kirkpatrick, R.W. Buchanan, D.E. Ross, W.T. Carpenter // Arch. Gen. Psychiatry. – 2001. – Vol.58. – P. 165-171.
36. McClellan J.M. Schizophrenia: a common disease caused by multiple rare alleles / J.M. McClellan, E. Susser, M.C. King // British Journal Psychiatry. – 2007. – №3. Vol.190. – P. 194-199.
37. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients / V. Molina, J. Sanz, F. Sarramea et al. // Psychiatry Res. – 2004. – Vol.131(1). – P. 45-56.
38. Murray R. Assessing Symptom Dimensions in Psychosis: Towards the Diagnostic and Statistical Manual of Mental Disorders – V (DSM-V) and the International Classification of Diseases and Health-Related Problems – (11th Revision) (ICD-11) / R. Murray // Presentation at Satellite Sympo¬sium «Treatment of Schizophrenia: Towards a Comprehensive Approach» on the occasion of the 20th ECNP Congress, 16 October 2007. – P. 1-12.
39. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study / M. Nakamura, D.F. Salisbury, Y. Hirayasu et al.// Biol. Psychiatry. – 2007. – Vol.62(7). – P. 773-783.
40. Roceedings and Data From The schizophrenia Summit: a clinical appraisal to improve the management of schizophrenia / H.A. Nasrallah, M.S. Keshavan, F.M. Benes et al. // J. Clin. Psychiatry. – 2009. – Vol.70. – Suppl 1. – P. 4-46.
41. National Collaborating Centre for Mental Health: Schizophrenia. Full national clinical guidelines on core interventions in primary and secondary care. – London, Gaskell and British Psychological Society, 2003. – 252 p.
42. O’Donovan M.C. Schizophrenia: complex genetics, not fairy tales / M.C. O’Donovan, N. Cradock, M.J. Owen // Psychol. Med. – 2008. – P. 1-3.
43. Peralta V. Diagnostic significance of Schneider’s first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders / V. Peralta, M.J. Cuesta // Br. J. psychiatry. – 1999. – Vol.174. – P. 243-248.
44. Size of burden of schizophrenia and psychotic disorders / W. Rossler,H.J. Salize, J. Van Os et al. // Eur. Neuropsychopharmacol. – 2005. – Vol.15(4). – P. 399-409.
45. Rund B.R. A review of longitudinal studies of cognitive functions in schizophrenia patients / B.R. Rund // Schizophr. Bull. – 1998. – Vol.24. – P. 425-435.
46. Sato M. Renaming schizophrenia: a Japanese perspective / M. Sato // World Psychiatry. – 2006. – Vol.1. – P. 53-55.
47. Neuropsychological function decrement in schizophrenia: selective impairment in memory and learning / A.J. Saykin, R.C. Gur, R.E. Gur et al. // Arch. Gen psychiatry. – 1991. – Vol.48(7). – P. 618-624.
48. Selemon L.D. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17 / L.D. Selemon, G. Rajkowska, P.S. Goldman-Rakic // Arch. Gen. Psychiatry. – 1995. – Vol.52(10). – P. 805-818; discussion 819-820.
49. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and expression / R.E. Straub, B.K. Lipska, M.F. Egan et al. // Mol. Psychiatry. – 2007. – Vol.12(9). – P. 854-869.
50. Strauss J.S. The diagnosis and understanding of schizophrenia: III. Speculations on the process that underlie schizophrenic symptoms and signs / J.S. Strauss, W.T. Carpenter, J.J. Bartko // Shcizophs. Ball. – 1974. – Vol.11. – P. 61-76.
51. Sullivan P.F. The dice are rolling for schizophrenia genetics / P.F. Sulli¬van // Psychol. Med. – 2008. – P. 1-4.
52. Tunbrige E.M. Catechol-o-menthyltransferase, cognition, and psychosis: Val158Met and beyond / E.M. Tunbrige, P.J. Harrison, D.R. Weinberger // Biol. Psychiatry. – 2006. – Vol.60(2). – P. 141-151.
53. Focal gray matter changes in schizophrenia across the course of the ilness: a 5-year follow-up study / N.E. Van Haren, H.E. Pol Hulshoff, H.G. Schnack et al. // Neuropsychopharmacology. – 2007. – Vol.32(10). – P. 2057-2066.
54. Van Os J. Salience syndrome replaces schizophrenia in DSM-V and ICD¬11: psychiatry’s evidence-based entry into the 21st century? / J. Os Van // ActaPsychiatr Scand. – 2009. – №120(5). – Р. 363-72.
55. Van Os J. A salience dysregulation syndrome / J. Os Van // Br. J. Psychiatry. – 2009. – № 194(2). – Р. 101-103.
56. Van Os J. Schizophrenia / J. Os Van, S. Kapur // Lancet. – 2009. – №374(9690). – Р. 635-45.
2. Джонс П. Шизофрени / П. Джонс, П. Бакли. – М.: Медпрессинформ, 2008. – 192 с.
3. Руководство по психиатрии. Т.1 / Под ред. Снежневского А.В. – М.: Медицина, 1983. – С. 299.
4. Руководство по психиатрии.Т.1 / Под ред. Тиганова А.С. – М.: Медицина, 1989.
5. Уотсон Д. ДНК и мозг (впоисках генов психических заболеваний) / Д. Уотсон // Лекция 3 июля 2008 г. в Москве, http://elementy.ru/lib/430639.
6. The spectrum of psychoyic disorders: neurobiology, etiology, and psthogenesis / Ahmed, Iqbal, Fujii, Daryl. – Cambridge, UK: Cambridge University Press, 2007.
7. Andreasen N.C. Negative symptoms in schizophrenia / N.C. Andreasen // Arch. Gen. Psychiatry. – 1982. – Vol.39. – P. 784-788.
8. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives / B. Arts, N. Jabben, L. Krabbendam et al. // Psychol. Med. – 2008. – Vol.38. – P. 771-785.
9. Awad A.G. The burden of schizophrenia on caregivers: a review / A.G. Awad, Voruganti L.N. // Pharmacoeconomics. – 2008. – Vol.26(2). – P. 149-162.
10. Benes F.M. Quantiativecytoarchitectural studies of the cerebral cortex of schizophrenics / F.M. Benes, J. Davidson, E.D. Bird // Arch. Gen. Psychiatry. – 1986. – Vol.43(1). – P. 31-35.
11. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond / Bora et al. // Schizophren. Bull. – 2010. – Vol.36. – P. 36-42.
12. Buchanan R.W. Schizophrenia. Introduction and overview / R.W. Buchanan, W.T. Carpenter, In: Kaplan B., Sadock V. // Comprehensive textbook of psychiatry. 7th edition, vol.I. – Philadelphia, Lippincotte, Williams and Wilkins. 2000. – P. 1096-1110.
13. genetic variation in MAOA modulates ventromedial prefrontal circuity mediating individual differences in human personality / J.W. Buckholtz, J.H. Callicott, B. Kolachana et al.// Mol. Psychiatry. – 2008. – Vol.13(3). – P. 313-324.
14. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia / J.H. Callicott, R.E. Straub, L. Pezawas et al. // Proc. Natl. Acad. Sci USA. – 2005. – Vol.102(24). – P. 8627-8632.
15. Campaign for The Abolition of The Schizophrenia Label (http://www/caslcampaign.com/).
16. Association of DISC1/TRAX halotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory / T.D. Cannon, W. Hennah, T.G. van Erp et al. // Arch. Gen. Psychiatry. – 2005. – Vol.62(11). – P. 1205-1213.
17. Collier D.A. Schizophrenia: the polygene princess and the pea / D.A. Colli¬er // Psychol. Med. – 2008. – P. 1-5.
18. Crespi Psychosis and autism as diametrical disorders of the social brain (http://www.bbsonline.org/Preprints/Crespi-02162007).
19. Crow T.J. The two syndrome concept, origins and current status / T.J. Crow // Schiz. Bull. – 1985. – Vol.11. – P. 471-477.
20. Crow T.J. How and why genetic linkage has not solved the problem of psychosis: rewiew and hypothesis / T.J. Crow // Am J. Psychiatry. – 2007. – V.164. – P. 13-21.
21. Crow T.J. The emperors of the schizophrenia polygene have no clothes / T.J. Crow // Psychol. Med. – 2008. – P. 1-5.
22. Cuesta M.J. Empirical validation of competing definitions of schi¬zophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis / M.J. Cuesta, V. Peralta, A. Zarzuela // Schizophr. Res. – 2007. – Vol.95. – P. 39-47.
23. Dysfunctional Perception Syndrome (http://astridvanwoerkom.wordpress.com/2009/10/09/schizophrenia-now¬called-dysfunctional-perception-syndrom/)
24. Neuropsychologic functioning among the nonspecific relatives of schi¬zophrenic patients: a four-year follow up study / S.V. Faraone, I.J. Seidman, W.S. Kremen et al. // J. Abnorm. Psychol. – 1999. – Vol.108. – P. 176-181.
25. Jackson J.H. Selected writings / J.H. Jackson. – Holder and Stoughton, London, 1931. – Vol.1. – 411 p.
26. The G72/G30 gene complex and cognitive abnormalities in schizophrenia / T.E. Goldberg, R.E. Straub, J.H. Callicott et al. // Neuropsychopharmacol¬ogy. – 2006. – Vol.31(9). – P. 2022-2032.
27. Green M.F. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS / M.F. Green, R.S. Kern, R.K. Heaton // Schizophr. Res. – 2004. – Vol.72(1). – P. 41-51.
28. Griesinger W. Die Pathologic und Therapie der psychischen Krankheiten / W. Griesinger. – Braunsduweig: Verlag von Friedrich Wreden, 1871. – Р. 53-85.
29. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms / J. Hall, H.C. Whalley, E. d. Job et al. // Nat. Neurosci. – 2006. – Vol.9(12). – P. 1477-1478.
30. Heinrichs R.W. The primacy of cognition in schizophrenia / R.W. Heinrichs // Am. Psychol. – 2005. – Vol.60(3). – P. 229-242.
31. Neuropsychological dysfunction in antipsychotic-naХve first-episode uni¬polar psychotic depression / S.K. Hill, M.S. Keshavan, M.E. Thase et al. // Am. J. Psychiatry. – 2004. – Vol.161(6). – P. 996-1003.
32. Hoche A. Die Medizin der Gegenwart in Sellbstdarstellungen, 1925.
33. Kay S.R. Cognitive abnormality in schizophrenia: A dual process model / S.R. Kay, M.M. Singh // Biol. Psychiat. – 1979. – Vol.14. – P. 155-176.
34. Keefe R.S. Defining a cognitive function decrement in schizophrenia / R.S. Keefe, C.E. Eesley, M.P. Poe // Biol. Psychiatry. – 2005. – Vol.57, №6. – P. 688-692.
35. A Separate Disease within the Syndrome of Schizophrenia / B. Kirkpatrick, R.W. Buchanan, D.E. Ross, W.T. Carpenter // Arch. Gen. Psychiatry. – 2001. – Vol.58. – P. 165-171.
36. McClellan J.M. Schizophrenia: a common disease caused by multiple rare alleles / J.M. McClellan, E. Susser, M.C. King // British Journal Psychiatry. – 2007. – №3. Vol.190. – P. 194-199.
37. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients / V. Molina, J. Sanz, F. Sarramea et al. // Psychiatry Res. – 2004. – Vol.131(1). – P. 45-56.
38. Murray R. Assessing Symptom Dimensions in Psychosis: Towards the Diagnostic and Statistical Manual of Mental Disorders – V (DSM-V) and the International Classification of Diseases and Health-Related Problems – (11th Revision) (ICD-11) / R. Murray // Presentation at Satellite Sympo¬sium «Treatment of Schizophrenia: Towards a Comprehensive Approach» on the occasion of the 20th ECNP Congress, 16 October 2007. – P. 1-12.
39. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study / M. Nakamura, D.F. Salisbury, Y. Hirayasu et al.// Biol. Psychiatry. – 2007. – Vol.62(7). – P. 773-783.
40. Roceedings and Data From The schizophrenia Summit: a clinical appraisal to improve the management of schizophrenia / H.A. Nasrallah, M.S. Keshavan, F.M. Benes et al. // J. Clin. Psychiatry. – 2009. – Vol.70. – Suppl 1. – P. 4-46.
41. National Collaborating Centre for Mental Health: Schizophrenia. Full national clinical guidelines on core interventions in primary and secondary care. – London, Gaskell and British Psychological Society, 2003. – 252 p.
42. O’Donovan M.C. Schizophrenia: complex genetics, not fairy tales / M.C. O’Donovan, N. Cradock, M.J. Owen // Psychol. Med. – 2008. – P. 1-3.
43. Peralta V. Diagnostic significance of Schneider’s first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders / V. Peralta, M.J. Cuesta // Br. J. psychiatry. – 1999. – Vol.174. – P. 243-248.
44. Size of burden of schizophrenia and psychotic disorders / W. Rossler,H.J. Salize, J. Van Os et al. // Eur. Neuropsychopharmacol. – 2005. – Vol.15(4). – P. 399-409.
45. Rund B.R. A review of longitudinal studies of cognitive functions in schizophrenia patients / B.R. Rund // Schizophr. Bull. – 1998. – Vol.24. – P. 425-435.
46. Sato M. Renaming schizophrenia: a Japanese perspective / M. Sato // World Psychiatry. – 2006. – Vol.1. – P. 53-55.
47. Neuropsychological function decrement in schizophrenia: selective impairment in memory and learning / A.J. Saykin, R.C. Gur, R.E. Gur et al. // Arch. Gen psychiatry. – 1991. – Vol.48(7). – P. 618-624.
48. Selemon L.D. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17 / L.D. Selemon, G. Rajkowska, P.S. Goldman-Rakic // Arch. Gen. Psychiatry. – 1995. – Vol.52(10). – P. 805-818; discussion 819-820.
49. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and expression / R.E. Straub, B.K. Lipska, M.F. Egan et al. // Mol. Psychiatry. – 2007. – Vol.12(9). – P. 854-869.
50. Strauss J.S. The diagnosis and understanding of schizophrenia: III. Speculations on the process that underlie schizophrenic symptoms and signs / J.S. Strauss, W.T. Carpenter, J.J. Bartko // Shcizophs. Ball. – 1974. – Vol.11. – P. 61-76.
51. Sullivan P.F. The dice are rolling for schizophrenia genetics / P.F. Sulli¬van // Psychol. Med. – 2008. – P. 1-4.
52. Tunbrige E.M. Catechol-o-menthyltransferase, cognition, and psychosis: Val158Met and beyond / E.M. Tunbrige, P.J. Harrison, D.R. Weinberger // Biol. Psychiatry. – 2006. – Vol.60(2). – P. 141-151.
53. Focal gray matter changes in schizophrenia across the course of the ilness: a 5-year follow-up study / N.E. Van Haren, H.E. Pol Hulshoff, H.G. Schnack et al. // Neuropsychopharmacology. – 2007. – Vol.32(10). – P. 2057-2066.
54. Van Os J. Salience syndrome replaces schizophrenia in DSM-V and ICD¬11: psychiatry’s evidence-based entry into the 21st century? / J. Os Van // ActaPsychiatr Scand. – 2009. – №120(5). – Р. 363-72.
55. Van Os J. A salience dysregulation syndrome / J. Os Van // Br. J. Psychiatry. – 2009. – № 194(2). – Р. 101-103.
56. Van Os J. Schizophrenia / J. Os Van, S. Kapur // Lancet. – 2009. – №374(9690). – Р. 635-45.
Downloads
Published
2019-07-10
How to Cite
Винник, М. І., Бежук, Ю. М., Ромаш, І. Р., Бондар, О. М., & Краснопольська, І. І. (2019). SOME ACTUAL PROBLEMSIN DIAGNOSTIC, CLASSIFICATION AND PSYCHOPATHOLOGY OF SCHIZOPHRENIA. PRECARPATHIAN BULLETIN OF THE SHEVCHENKO SCIENTIFIC SOCIETY Pulse, (4(24), 128–138. Retrieved from https://pvntsh.nung.edu.ua/index.php/pulse/article/view/840
Issue
Section
КЛІНІЧНА МЕДИЦИНА
